Wegovy®
Brand Name: Wegovy® 0.25mg
Composition: Semaglutide 0.25mg, solution for injection in a pre-filled pen, r-DNA Origin
Product Description
Medical Info
Wegovy® 0.25mg is an advanced prescription biologic therapy containing Semaglutide, a potent glucagon-like peptide-1 (GLP-1) receptor agonist produced via recombinant DNA technology. Developed by Novo Nordisk, this 0.25mg presentation serves as the initial low-dose starter pen designed for gradual clinical escalation.Administered as a convenient once-weekly subcutaneous injection using the specialized FlexTouch® device, it is indicated alongside lifestyle modifications for chronic weight management in adults with obesity or overweight individuals experiencing weight-related comorbidities. By effectively mimicking natural satiety hormones, it regulates appetite, delays gastric emptying, and significantly reduces long-term cardiovascular risks.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
